Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for Schrodinger NASDAQ SDGR

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
Finance_Accounting
0
SHARES
14
VIEWS
Share on FacebookShare on Twitter

Analysts have been giving mixed ratings for Schrodinger (NASDAQ: SDGR) over the past three months, with some feeling bullish, others somewhat bullish, and some showing indifference or slight bearish sentiments.

The average 12-month price target for Schrodinger stands at $36.88, with a high estimate of $50.00 and a low estimate of $26.00. Various firms, including Goldman Sachs, Keybanc, Citigroup, B of A Securities, Piper Sandler, TD Cowen, and Craig-Hallum, have made adjustments to their ratings and price targets for Schrodinger recently.

Recent forecasts suggest an average price target of $44.14 for Schrodinger, with a high forecast of $60.00 and a low forecast of $35.00. The consensus rating for Schrodinger is Strong Buy, with 6 buy ratings and 1 hold rating.

Analysts’ assessments range from ‘Outperform’ to ‘Underperform,’ reflecting their expectations based on market conditions and company performance. The stock has experienced fluctuations in analyst recommendations in recent months, with some firms revising their price targets and ratings.

As of March 2, 2024, the outlook for Schrodinger remains dynamic and subject to change based on ongoing evaluations by market analysts.

SDGR Stock Analysis: March 2, 2024 Performance Review and Potential Volatility

On March 2, 2024, SDGR stock closed at $26.81, marking a $1.35 increase from the previous market close. This represented a 5.30% rise in the stock price. However, SDGR is currently trading near the bottom of its 52-week range and below its 200-day simple moving average.

SDGR experienced a slight drop of $0.11 in after-hours trading, indicating potential volatility in the stock price.

The performance of SDGR on March 2, 2024, shows a mix of positive and negative movements. Investors should conduct thorough research and analysis before making any investment decisions related to SDGR stock.

SDGR Stock Shows Impressive Financial Results: Revenue Up 19.73% for the Year

On March 2, 2024, SDGR stock showed impressive performances as the company reported strong financial results for the past year and the last quarter. According to data from CNN Money, SDGR’s total revenue for the year stood at $216.67 million, showing a significant increase of 19.73% compared to the previous year. Additionally, the total revenue for the last quarter was reported at $74.13 million, marking a substantial increase of 74.13% since the previous quarter.

Moreover, SDGR’s net income for the year was $40.72 million, reflecting a remarkable increase of 127.29% since the previous year. However, the net income for the last quarter was reported at -$30.67 million, indicating a loss for the quarter. Despite this, the net income still showed an improvement of 50.55% since the previous quarter.

Furthermore, SDGR’s earnings per share (EPS) for the year were $0.54, representing a significant increase of 125.91% since the previous year. The EPS for the last quarter was reported at -$0.43, showing a loss per share for the quarter. Nonetheless, the EPS still showed an improvement of 50.71% since the previous quarter.

Tags: SDGR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Analysts Remain Bullish on Vertex with Price Target Increases

Biotechnology Trading online

Challenges and Opportunities The Story of Gritstone Bio

Finance_ Chart Down

Citigroup Analyst Reiterates Sell Rating on Best Buy Co with Increased Price Target

Recommended

BigBearai Holdings Stock

BigBear.ai Faces Critical Test as Revenue Plummets and Losses Mount

6 months ago
D-Wave Quantum Stock

D-Wave Quantum: CFO’s Multi-Million Dollar Exit Amidst Major Capital Raise

4 months ago
Brightcove Stock

Bending Spoons Forges AI-Powered Streaming Future with Brightcove at the Core

6 months ago
Microsoft Stock

Microsoft Faces Critical Earnings Test Amid AI Expectations

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

Trending

Bionxt Solutions Stock
Healthcare

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

by SiterGedge
March 25, 2026
0

BioNxt Solutions has formally initiated the commercial phase for its sublingual drug delivery platform, marking a significant...

Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon
  • Ocugen Shares Slide Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com